Your account is not claimed yet. You can sign up with ORCID to claim your account.

Amir Ahmed Toor (Amir Toor, Amir A Toor)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

European journal of haematology

EJHaem

Bone marrow transplantation

Clinical & translational immunology

Virginia Commonwealth University Health System

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Virginia Commonwealth University Health System Sep 1o 2007

United States

Professor of Medicine :: Internal Medicine

Publications

Viktoriya Zelikson, Roy Sabo, Myrna Serrano, Younus Aqeel, Savannah Ward, Taha Al Juhaishi, May Aziz, Elizabeth Krieger, Gary Simmons, Catherine Roberts, Jason Reed, Gregory Buck, Amir Ahmed Toor
Allogeneic haematopoietic cell transplants as dynamical systems: influence of early-term immune milieu on long-term T-cell recovery. Clinical & translational immunology 12 (7) (2023)
Joshua Alexander Fein, Roni Shouval, Elizabeth Krieger, Stephen R Spellman, Tao Wang, Henning Baldauf, Katharina Fleischhauer, Nicolaus Kroeger, Mary M Horowitz, Martin J Maiers, Jeffrey S Miller, Mohamad Mohty, Arnon Nagler, Daniel J Weisdorf, Karl-Johan Malmberg, Amir Ahmed Toor, Johannes Schetelig, Rizwan Romee, John Koreth
Systematic Evaluation of Donor-KIR/Recipient-HLA Interactions in HLA-matched Hematopoietic Cell Transplantation for AML. Blood advances (2023)
Ghada Elgohary, Amir Ahmed Toor, Usama Gergis
Engraftment syndrome after allogeneic stem cell transplantation: a systematic review and meta-analysis. Bone marrow transplantation (2022)
Elizabeth Krieger, Rehan Qayyum, Armand Keating, Amir Ahmed Toor
Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML. Bone marrow transplantation 56 (11) (2021)
Amir M Ansari, Adam Khorasanchi, Armaghan Faghihimehr, Amir Ahmed Toor
Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia. Clinical case reports 9 (10) (2021)
Naif I AlJohani, Amir Ahmed Toor
What is the minimum adequate busulfan dose for patients with sickle cell disease undergoing reduced intensity conditioning with fludarabine, busulfan, and anti-thymocyte globulin? EJHaem 2 (3) (2021)
Adam Khorasanchi, Amir M Ansari, Wendy Bottinor, Gary Simmons, Antonio Abbate, Amir Ahmed Toor
Transient left ventricular dysfunction following chimeric antigen receptor T-cell-mediated encephalopathy: A form of stress cardiomyopathy. EJHaem 3 (1) (2021)
Mahmood Rasheed, Gary Simmons, Bernard Fisher, Kevin Leslie, Jason Reed, Catherine Roberts, Ramesh Natarajan, Alpha Fowler, Amir Ahmed Toor
Reduced plasma ascorbic acid levels in recipients of myeloablative conditioning and hematopoietic cell transplantation. European journal of haematology 103 (4) (2019)
Ariel Sindel, Trevor Taylor, Alden Chesney, William Clark, Alpha A Fowler, Amir Ahmed Toor
Hematopoietic stem cell mobilization following PD-1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid. European journal of haematology 103 (2) (2019)
Vishal Koparde, Badar Abdul Razzaq, Tara Suntum, Roy Sabo, Allison Scalora, Myrna Serrano, Max Jameson-Lee, Charles Hall, David Kobulnicky, Nihar Sheth, Juliana Feltz, Daniel Contaifer, Dayanjan Wijesinghe, Jason Reed, Catherine Roberts, Rehan Qayyum, Gregory Buck, Michael Neale, Amir Ahmed Toor
Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation. PloS one 12 (12) (2017)

Amir Ahmed Toor.css-eqlu8i{font-size:small;padding-left:4px;} (Amir Toor, Amir A Toor)

Publication Activity (10 Years)

Top Topics

Top Venues

Amir Ahmed Toor (Amir Toor, Amir A Toor)